Pulse Biosciences (PLSE) Enterprise Value (2015 - 2025)

Pulse Biosciences' Enterprise Value history runs 11 years deep, the most recent figure standing at -$80.7 million for Q4 2025.

• In Q4 2025, Enterprise Value rose 31.6% year-over-year to -$80.7 million; the TTM figure through Dec 2025 stood at -$80.7 million (up 31.6% YoY), while the FY2025 annual figure was -$80.7 million, up 31.6% from the prior year.
• Enterprise Value was -$80.7 million for Q4 2025 at Pulse Biosciences, up from -$95.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$12.7 million in Q1 2022 to a low of -$119.3 million in Q1 2025.
• Historically, Enterprise Value has averaged -$60.4 million across 5 years, with a median of -$54.3 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Enterprise Value tumbled 453.73% in 2021, then soared 78.83% in 2022.
• A 5-year view of Enterprise Value shows it stood at -$44.4 million in 2021, then tumbled by 30.67% to -$58.0 million in 2022, then rose by 23.47% to -$44.4 million in 2023, then sank by 166.06% to -$118.0 million in 2024, then soared by 31.6% to -$80.7 million in 2025.
• The last three Enterprise Value figures came in at -$80.7 million (Q4 2025), -$95.2 million (Q3 2025), and -$106.3 million (Q2 2025), per Business Quant data.